Clinical Trials on Advanced Solid Tumors in Switzerland
Total 544 results
-
PIQUR Therapeutics AGCompletedAdvanced Solid TumorsSwitzerland
-
Southern Europe New Drug OrganizationPierre Fabre Laboratories; AgennixUnknown
-
Southern Europe New Drug OrganizationNovartisUnknownAdvanced Solid TumorsSwitzerland
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
Southern Europe New Drug OrganizationNovartis; Schering-PloughUnknownAdvanced Solid TumorsItaly, Switzerland
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Swiss Group for Clinical Cancer ResearchRecruitingAdvanced Solid TumorsSwitzerland
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
TOLREMO therapeutics AGRecruitingCancer | Adult Solid Tumor | Advanced Solid Tumor | Adult DiseaseSpain, Switzerland
-
Philogen S.p.A.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorItaly, Germany, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
Debiopharm International SARecruitingAdvanced Solid TumorsSpain, United States, Switzerland
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid TumorsUnited States, Spain, Canada, Norway, Switzerland
-
Swiss Group for Clinical Cancer ResearchImmunophotonics, Inc.RecruitingAdvanced Solid TumorsSwitzerland
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
T3 Pharmaceuticals AGRecruiting
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsCanada, United States, Denmark, Israel, Switzerland
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorsCanada, United States, Spain, France, Switzerland
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Italy, Korea, Republic of, Spain, Belgium, Canada, Germany, United States, Hong Kong, Hungary, China, Czechia, Taiwan, France, Poland, Thailand, Netherlands
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsChina, United States, Australia, Canada, Chile, Israel, Japan, Korea, Republic of, Panama, Poland, Spain, Switzerland, Turkey, New Zealand, Taiwan
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorsSpain, Japan, Taiwan, Italy, Switzerland, Israel, United States, Singapore
-
Merck Sharp & Dohme LLCRecruitingAdvanced or Metastatic Solid TumorsCanada, Switzerland, United States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States, China, Croatia, Japan, Latvia, Poland, Brazil, Lithuania, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerNetherlands, Switzerland, Denmark, United States
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
University Hospital, Basel, SwitzerlandCompleted
-
University Hospital, Basel, SwitzerlandNot yet recruiting
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
Glycotope GmbHCompleted
-
Oncology Institute of Southern SwitzerlandEnte Ospedaliero Cantonale, Bellinzona; Istituto Cantonale di PatologiaRecruitingLymphoma | Advanced Solid TumorSwitzerland
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Kantonsspital GraubuendenUnknownUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol SpecificSwitzerland
-
AstraZenecaTerminatedSolid TumorsItaly, Switzerland
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersSpain, Switzerland, United Kingdom, United States
-
Glycotope GmbHGlycotope Biotechnology GmbHCompleted
-
Centre Hospitalier Universitaire VaudoisCompleted
-
Centre Hospitalier Universitaire VaudoisActive, not recruiting
-
Novartis PharmaceuticalsCompletedAdvanced and Selected Solid TumorsBelgium, Spain, Canada, Switzerland, United States
-
Maxivax SAActive, not recruiting
-
Centre Hospitalier Universitaire VaudoisTerminatedSolid Tumor, AdultSwitzerland
-
University of ZurichTerminatedCT Perfusion and MRI Perfusion in Solid TumorsSwitzerland
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more